A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction
For example, the compound 13 (racemic) is a very week IRAP inhibitor (Lukaszuk et al., 2011) and compound 14 with a 4-hydroxydiphenylmethane scaffold as a substitute for Tyr 2 is essentially inactive (Figure 4) (Andersson et al., 2008)
This can make you feel groggy or sluggish when you wake up, even if you technically slept for several hours
Kim CH, Chung HJ, Lee HK, Huganir RL (2001)
Why Researchers Compare It With Tirzepatide and Retatrutide Cagrilintide is usually compared with tirzepatide and retatrutide because all three sit in the next-generation metabolic-peptide discussion